Research / NVDA / Fundamental state Inspectable configuration
State dimensions Filing 0001045810-26-000052 General Corporate
Debt relative to revenue 10th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
10.38% · OPTIONAL · VALID
Capex intensity 15th Own-history percentile · N=13
Evidence method Level · gp.fundamentals.capex_revenue_ratio
2.15% · OPTIONAL · VALID
Operating cash generation 95th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
61.68% · OPTIONAL · VALID
Revenue growth 63th Own-history percentile · N=19
Evidence method Yoy · gp.fundamentals.revenue
85.23% · CORE · VALID
Inventory pressure 55th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
31.61% · OPTIONAL · VALID
Gross margin 85th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
74.93% · CORE · VALID
Operating margin 100th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
65.60% · CORE · VALID
R&D intensity 0th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
7.74% · OPTIONAL · VALID
SBC intensity 0th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
2.36% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 25 states Self-history eligible
Oct 31, 2021 0/9 normalized Level 3 Jan 30, 2022 0/8 normalized Level 3 May 1, 2022 0/8 normalized Level 3 Jul 31, 2022 6/8 normalized Level 3 Oct 30, 2022 7/8 normalized Level 3 Jan 29, 2023 7/8 normalized Level 3 Apr 30, 2023 7/8 normalized Level 3 Jul 30, 2023 8/8 normalized Level 3 Oct 29, 2023 8/8 normalized Level 3 Jan 28, 2024 8/9 normalized Level 3 Apr 28, 2024 8/9 normalized Level 3 Jul 28, 2024 8/9 normalized Level 3 Oct 27, 2024 8/9 normalized Level 3 Jan 26, 2025 9/9 normalized Level 3 Apr 27, 2025 9/9 normalized Level 3 Jul 27, 2025 9/9 normalized Level 3 Oct 26, 2025 9/9 normalized Level 3 Jan 25, 2026 9/9 normalized Level 3 Apr 26, 2026 9/9 normalized Level 3 Jul 26, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 3.92%
Current 10.38%
Delta 6.46% Capex Intensity Decreased
Previous 2.80%
Current 2.15%
Delta -0.65% Cash Generation Increased
Previous 47.57%
Current 61.68%
Delta 14.12% Growth Increased
Previous 65.47%
Current 85.23%
Delta 19.75% Inventory Pressure Increased
Previous 9.91%
Current 31.61%
Delta 21.70% Margin Increased
Previous 71.07%
Current 74.93%
Delta 3.87% Profitability Increased
Previous 60.38%
Current 65.60%
Delta 5.21% R And D Intensity Decreased
Previous 8.57%
Current 7.74%
Delta -0.82% Sbc Intensity Decreased
Previous 2.96%
Current 2.36%
Delta -0.59% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.